Advances in the Synthetic Approaches to β‑Secretase (BACE-1) Inhibitors in Countering Alzheimer’s: A Comprehensive Review

Advances in the Synthetic Approaches to β‑Secretase (BACE-1) Inhibitors in Countering Alzheimer’s: A Comprehensive Review

Saved in:

Bibliographic Details
Main Authors:	Yogeesh M, Nitinkumar S. Shetty
Format:	Article
Language:	English
Published:	American Chemical Society 2025-08-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.5c04467
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Concatenation of molecular docking and molecular simulation of BACE-1, γ-secretase targeted ligands: in pursuit of Alzheimer’s treatment
by: Nasimudeen R. Jabir, et al.
Published: (2021-01-01)

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
by: Ulf Neumann, et al.
Published: (2018-09-01)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025-03-01)

A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease
by: Justyna A Dobrowolska Zakaria, et al.
Published: (2018-10-01)

Recent advances in the synthesis of polymer supported catalysts: a review
by: C. H. Raksha, et al.
Published: (2025-05-01)

Interaction Prediction on BACE-1 Inhibitors Data for Alzheimer Disease using Message Passing Neural Network
by: Bihter Daş, et al.
Published: (2025-02-01)

Retraction of “Design, Synthesis, and Biological Evaluation of Notopterol Derivatives as Triple Inhibitors of AChE/BACE1/GSK3β for the Treatment of Alzheimer’s Disease”
by: Nan Wang, et al.
Published: (2025-07-01)

RETRACTED: Design, Synthesis, and Biological Evaluation of Notopterol Derivatives as Triple Inhibitors of AChE/BACE1/GSK3β for the Treatment of Alzheimer’s Disease
by: Nan Wang, et al.
Published: (2022-08-01)

Targeted delivery of BACE1 siRNA for synergistic treatment of Alzheimer's disease
by: Zhaohan Li, et al.
Published: (2025-08-01)

BACE1 as an early biomarker and its relevance to risk factors for Alzheimer’s disease
by: Masuo Ohno
Published: (2025-10-01)

Developing Novel Beta-Secretase Inhibitors in a Computer Model as a Possible Treatment for Alzheimer’s Disease
by: Tassanee Ongtanasup, et al.
Published: (2025-01-01)

An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease
by: Yasuhiko Kizuka, et al.
Published: (2015-01-01)

Beneficial effect of antibodies against β- secretase cleavage site of APP on Alzheimer's-like pathology in triple-transgenic mice.
by: Inna Rabinovich-Nikitin, et al.
Published: (2012-01-01)

Inactivation of γ‐secretases leads to accumulation of substrates and non‐Alzheimer neurodegeneration
by: Hermien Acx, et al.
Published: (2017-06-01)

The manipulator behind “Scissors”: γ -secretase and its modulators in Alzheimer’s disease
by: Gao Ning, et al.
Published: (2025-08-01)

ABCG1 and ABCG4 Suppress γ-Secretase Activity and Amyloid β Production.
by: Osamu Sano, et al.
Published: (2016-01-01)

AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model
by: Marika Marino, et al.
Published: (2022-03-01)

The resveratrol trimer miyabenol C inhibits β-secretase activity and β-amyloid generation.
by: Jin Hu, et al.
Published: (2015-01-01)

Multitarget drugs as potential therapeutic agents for alzheimer’s disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors
by: Pedro González-Naranjo, et al.
Published: (2022-12-01)

Noninvasive Assessment of β‐Secretase Activity Through Click Chemistry‐Mediated Enrichment of Neuronal Extracellular Vesicles to Detect Alzheimer's Disease
by: Hyoyong Kim, et al.
Published: (2025-07-01)

Gnb5 is a negative regulator of the BACE1-mediated Aβ generation and ameliorates cognitive deficits in a mouse model of Alzheimer's disease.
by: Shaokun Chen, et al.
Published: (2025-06-01)

Increased Plasma β‐Secretase 1 Activity Correlates With Neurodegeneration in Cerebral Small Vessel Disease
by: Ya Su, et al.
Published: (2024-12-01)

Amino Acid Sequence and Structural Comparison of BACE1 and BACE2 Using Evolutionary Trace Method
by: Hoda Mirsafian, et al.
Published: (2014-01-01)

A Novel RAGE Modulator Induces Soluble RAGE to Reduce BACE1 Expression in Alzheimer's Disease
by: Seung‐Hyun Baek, et al.
Published: (2025-02-01)

α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP.
by: Hazel L Roberts, et al.
Published: (2017-01-01)

A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP.
by: April M Weissmiller, et al.
Published: (2015-01-01)

γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct
by: Yong Ran, et al.
Published: (2017-05-01)

Liraglutide improves cognition function in streptozotocin-induced diabetic rats by downregulating β-secretase and γ-secretase and alleviating oxidative stress in HT-22 cells
by: Lou-yan Ma, et al.
Published: (2025-03-01)

Decrease in p3‐Alcβ37 and p3‐Alcβ40, products of Alcadein β generated by γ‐secretase cleavages, in aged monkeys and patients with Alzheimer's disease
by: Saori Hata, et al.
Published: (2019-01-01)

Plasmalogens Inhibit APP Processing by Directly Affecting γ-Secretase Activity in Alzheimer’s Disease
by: Tatjana L. Rothhaar, et al.
Published: (2012-01-01)

A novel generation of potent gamma-secretase modulators: Combat Alzheimer’s disease and Down syndrome–associated Alzheimer’s disease
by: Xu-Qiao Chen
Published: (2026-01-01)

Trisubstituted 1,3,5-Triazines and Their Effect on BACE1
by: Petra Majerova, et al.
Published: (2023-11-01)

Exploration of small molecules as inhibitors of potential BACE1 protein to treat amyloid cerebrovascular disease by employing molecular modeling and simulation approaches.
by: Zhizhong Wang, et al.
Published: (2025-01-01)

Presenilin-1 Familial Alzheimer Mutations Impair γ-Secretase Cleavage of APP Through Stabilized Enzyme–Substrate Complex Formation
by: Sujan Devkota, et al.
Published: (2025-07-01)

Evaluation of Selected Plant Phenolics via Beta-Secretase-1 Inhibition, Molecular Docking, and Gene Expression Related to Alzheimer’s Disease
by: Tugba Uçar Akyürek, et al.
Published: (2024-10-01)

Network pharmacology and metabolomics analysis of Tinospora cordifolia reveals BACE1 and MAOB as potential therapeutic targets for neuroprotection in Alzheimer’s disease
by: S. Amrutha, et al.
Published: (2025-03-01)

γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds
by: Johannes Trambauer, et al.
Published: (2025-02-01)

Correction: γ‑Secretase modulator resistance of an aggressive Alzheimer‑causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds
by: Johannes Trambauer, et al.
Published: (2025-04-01)

Intranasal Delivery of BACE1 siRNA and Berberine via Engineered Stem Cell Exosomes for the Treatment of Alzheimer&rsquo;s Disease
by: Sun C, et al.
Published: (2025-05-01)

Enhanced Blood‐Brain Barrier Penetrability of BACE1 SiRNA‐Loaded Prussian Blue Nanocomplexes for Alzheimer's Disease Synergy Therapy
by: Xiaoyuan Ding, et al.
Published: (2025-08-01)